Appendix A: List of Abbreviations
Updated
Reviewed
Acronym/ Abbreviation |
Definition |
---|---|
ABGs | arterial blood gasses |
ACTG | AIDS Clinical Trials Group |
AFB | acid-fact bacilli |
AIN | anal intraepithelial neoplasia |
ALT | alanine aminotransferase |
anti-HBc | hepatitis B core antibody |
anti-HBs | hepatitis B surface antibody |
ART | antiretroviral therapy |
ARV | antiretroviral |
ASCCP | American Society for Colposcopy and Cervical Pathology |
ASC-H | atypical squamous cells—cannot exclude high grade cervical squamous intraepithelial lesion |
ASC-US | atypical squamous cells of uncertain significance |
AST | serum aspartate aminotransferase |
AUC | area under the curve |
BA | bacillary angiomatosis |
BAL | bronchoalveolar lavage |
BID | twice a day |
BIW | twice a week |
CAP | community-acquired pneumonia |
CAPD | continuous ambulatory peritoneal dialysis |
CD4 | CD4 T lymphocyte cell |
CDC | Centers for Disease Control and Prevention |
CDI | Clostridium difficile-associated infection |
CES-D | Center for Epidemiologic Studies Depression Scale |
CFU | colony-forming unit |
CIA | chemiluminescence immunoassays |
CIN | cervical intraepithelial neoplasia |
Cmax | maximum concentration |
Cmin | minimum concentration |
CMV | cytomegalovirus |
CNS | central nervous system |
CPE | central nervous system penetration effectiveness |
CrCl | creatinine clearance |
CSF | cerebrospinal fluid |
CT | computed tomography |
CYP3A4 | Cytochrome P450 3A4 |
DAAs | direct acting antiviral agents |
DOT | directly observed therapy |
DS | double strength |
EDTA | ethylenediaminetetraacetic acid |
EIAs | enzyme immunoassays |
EM | erythema multiforme< |
FDA | Food and Drug Administration |
FTA-ABS | fluorescent treponemal antibody absorbed |
g | gram |
G6PD | Glucose-6-phosphate dehydrogenase |
GFR | glomerular filtration rate |
GI | gastrointestinal |
HAV | hepatitis A virus |
HBV | hepatitis B virus |
HCV | hepatitis C virus |
HHV-8 | human herpesvirus-8 |
HPA | hypothalamic-pituitary-adrenal |
HPV | human papillomavirus |
HSIL | high grade cervical squamous intraepithelial lesion |
HSV | herpes simplex virus |
HSV-1 | herpes simplex virus 1 |
HSV-2 | herpes simplex virus 2 |
ICP | intracranial pressure |
ICU | intensive care unit |
IFN | interferon |
IgG | immunoglobulin G |
IgM | immunoglobulin M |
IGRA | interferon-gamma release assays |
IM | intramuscular |
IND | investigational new drug |
IRIS | immune reconstitution inflammatory syndrome |
IRU | immune recovery uveitis |
IV | intravenous |
IVIG | ntravenous immunoglobulin |
JCV | JC virus |
KS | Kaposi Sarcoma |
LEEP | loop electrosurgical excision procedure |
LP | lumbar puncture |
LSIL | low grade squamous intraepithelial lesion |
LTBI | latent tuberculosis infection |
MAC | Mycobacterium avium complex |
MAI | Mycobacterium avium intracellulare |
MCD | multicentric Castleman’s disease |
MDR TB | multi-drug-resistant tuberculosis |
mg | milligram |
mmHg | millimeters of mercury |
MSM | men who have sex with men |
MTB | Mycobacterium tuberculosis |
NAA | nucleic acid amplification |
NNRTI | non-nucleoside reverse transcriptase inhibitor |
NRTI | nucleoside reverse transcriptase inhibitors |
NSAID | non-steroidal anti-inflammatory drugs |
NVP | nevirapine |
OI | opportunistic infection |
PCP | Pneumocystis pneumonia |
PCR | polymerase chain reaction |
PEL | primary effusion lymphoma |
PK | pharmacokinetic |
PML | progressive multifocal leukoencephalopathy |
PO | orally |
PORN | Progressive Outer Retinal Necrosis |
PPV | polysaccharide vaccine |
PSI | pneumonia severity index |
q(n)h | every ”n” hours |
qAM | every morning |
QID | four times a day |
qPM | every evening |
RPR | rapid plasma reagin |
RVR | rapid virological response |
SCr | serum creatinine |
SJS | Stevens-Johnson syndrome |
SLE | systemic lupus erythematosus |
SQ | subcutaneous |
SS | single strength |
STD | sexually transmitted disease |
SVR | sustained virologic response |
TB | tuberculosis |
TDM | therapeutic drug monitoring |
TE | Toxoplasma encephalitis |
TEN | toxic epidermal necrolysis |
TID | three times daily |
TIW | three times weekly |
TP-PA | T. pallidum particle agglutination |
TST | tuberculin skin test |
ULN | upper limit of normal |
VAIN | vaginal intra-epithelial neoplasia |
VDRL | Venereal Disease Research Laboratory |
VIII | vestibulocochlear |
VIN | vulvar intraepithelial neoplasia |
VZV | varicella zoster virus |
WBC | white blood cell |
WHO | World Health Organization |
XDR TB | extensively drug-resistant tuberculosis |
Abbreviation | Drug Name |
3TC | lamivudine |
5-FU | fluorouracil |
ATV/r | ritonavir-boosted atazanavir |
BCA | bichloroacetic acid |
BOC | boceprevir |
COBI | cobicistat |
ddA-TP | dideoxyadenosine triphosphate |
ddI | didanosine |
DHA | dihydroartemisinin |
EFV | efavirenz |
EMB | ethambutol |
EVG | elvitegravir |
FTC | emtricitabine |
INH | isoniazid |
MVC | maraviroc |
PCV13 | 13-valent pneumococcal conjugate vaccine |
PegIFN | peginterferon alfa |
PI | protease inhibitor |
PPV23 | 23-valent pneumococcal polysaccharides vaccine |
PZA | pyrazinamide |
RAL | raltegravir |
RBV | ribavirin |
RFB | rifabutin |
RIF | rifampin |
RPT | rifapentine |
SMX | sulfamethoxazole |
TCA | trichloroacetic acid |
TDF | tenofovir disoproxil fumarate |
TMP | trimethoprim |
TMP-SMX | trimethoprim-sulfamethoxazole |
TVR | telaprevir |
ZDV | zidovudine |
Download Guidelines
- Section Only PDF (153.18 KB)
- Full Guideline PDF (6 MB)
- Tables Only PDF (928.12 KB)